Download
slide1 n.
Skip this Video
Loading SlideShow in 5 Seconds..
Safety Savings Comprehensive Drug Free Workplace Programs Navigent3 navigent3 PowerPoint Presentation
Download Presentation
Safety Savings Comprehensive Drug Free Workplace Programs Navigent3 navigent3

Safety Savings Comprehensive Drug Free Workplace Programs Navigent3 navigent3

159 Vues Download Presentation
Télécharger la présentation

Safety Savings Comprehensive Drug Free Workplace Programs Navigent3 navigent3

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

    2. Over all up to 10% of worker age adults (18 yrs or older) abuse drugs, with some industries reporting significantly higher rates. The Department of Health and Human Services, Substance Abuse and Mental Health Services Administration's (SAMHSA) 2003 National Survey on Drug Use and Health (formerly the National Household Survey on Drug Abuse) reports that of 16.7 million illicit drug users age 18 or older, 12.4 million (74.3 percent) were employed either full or part time. (12.4M / 120M(private/non-government workers) = 10%. In addition, 14.9 million (77 percent) of the 19.4 million adults, age 18 or older, characterized with abuse of or dependence on alcohol or drugs were employed. The Bureau of Labor Statistics analyzed 1998 data from its Census of Fatal Occupational Injuries and estimated that 19 percent of the nation's workforce who die on the job test positive for alcohol and other drugs \1\ Weber, W., and Cox, C. ``Work-Related Fatal Injuries in 1998,'' Compensations and Working Conditions, Spring 2001, pp. 27- 29. \2\ Zwerling, C. ``Current practice and Experience in Drug and Alcohol Testing.'' Bulletin on Narcotics, vol. 45 (1993), pp. 155- 196. SAMHSA's 2000 National Household Survey on Drug Abuse analyzes alcohol and other drug use and abuse by industry sector. Notably, the construction and mining industries have the highest percentage of workers who reported current illicit drug use \3\ or have an alcohol dependence disorder or alcohol abuse disorder. \3\ The survey defined current illicit drug use as the use of marijuana, cocaine, heroin, hallucinogens, inhalants or non-medical use of prescription-type pain relievers, tranquilizers, stimulants, or sedatives in the past 30 days. Over all up to 10% of worker age adults (18 yrs or older) abuse drugs, with some industries reporting significantly higher rates. The Department of Health and Human Services, Substance Abuse and Mental Health Services Administration's (SAMHSA) 2003 National Survey on Drug Use and Health (formerly the National Household Survey on Drug Abuse) reports that of 16.7 million illicit drug users age 18 or older, 12.4 million (74.3 percent) were employed either full or part time. (12.4M / 120M(private/non-government workers) = 10%. In addition, 14.9 million (77 percent) of the 19.4 million adults, age 18 or older, characterized with abuse of or dependence on alcohol or drugs were employed. The Bureau of Labor Statistics analyzed 1998 data from its Census of Fatal Occupational Injuries and estimated that 19 percent of the nation's workforce who die on the job test positive for alcohol and other drugs \1\ Weber, W., and Cox, C. ``Work-Related Fatal Injuries in 1998,'' Compensations and Working Conditions, Spring 2001, pp. 27- 29.

    3. Corporate America has a $140B+/ year Problem due to Drug Abuse DRUGS OF ABUSES IS A HUGE PROBLEM.$140B ANNUAL COST TO THE US WORKPLACE. 10% of workers abuse drugs Varies by market, Construction is at 25% Each drug abuser on the payroll costs a corporation $10,000 a year Above occurs despite $1.5B spent on drug testing 95% of testing is pre-employment lab-based urine testing a porous screen DRUGS OF ABUSES IS A HUGE PROBLEM.$140B ANNUAL COST TO THE US WORKPLACE. 10% of workers abuse drugs Varies by market, Construction is at 25% Each drug abuser on the payroll costs a corporation $10,000 a year Above occurs despite $1.5B spent on drug testing 95% of testing is pre-employment lab-based urine testing a porous screen

    6. LOT# iDOA765011 Exp. 01/2006 Advertised Cut-offs (ng/ml) Tested Cut-offs (ng/ml) THC-COOH 4 750-1,000 NATIVE-THC 10,000 24,000-26,000 OPI 40 >20,000 OXY 6,000-25,000 >20,000 PCP 10 15-20 COC 20 35-40 d-METH 50 50-70 MDMA 50 100-150 d-AMP 50 250-300 iScreen manufactured for iTechnology Drug Class Detection Capabilities: AMP/MAMP/THC/PCP/COC/OPI Double Membrane immunoassay Temperature Requirements: 2-30C Purchase Price: $12.00/per test (sold in boxes of 25 tests) Shelf Life: 12-14 months Test Time: No mention of time allowed w/ clean oral cavity prior to oral fluid collection, 3 minute saliva collection, result interpretation at 10 minutes Test Materials Provided: Test Device, collector, procedure card, and package insert (same as above device) Confirmation Services: No confirmatory lab referral Oral Fluid Collection Testimonials: Same exact collector/Lot# as Oral Fluid Drug Screen Device, Unpleasant burnt/bitter taste, rigid inflexible collector that leaves an offensive after-taste, several donors requested to rinse cavity and spit after collection process was complete Manufacturer/Product Services: No customer or technical support offered, no product training available No automated result analyzer available for this product Sold to distributors only Testing Observations: 2 different oxycodone cutoffs were reported, insert provides THC-COOH cut-off, every test device was covered w/ a film of dust and dirt, this test requires larger amounts of sample to work, confirmation container leaked on several devices, lines began at the top and bottom edge and migrated inwards which made partial line formation Line intensity:LOT# iDOA765011 Exp. 01/2006 Advertised Cut-offs (ng/ml) Tested Cut-offs (ng/ml) THC-COOH 4 750-1,000 NATIVE-THC 10,000 24,000-26,000 OPI 40 >20,000 OXY 6,000-25,000 >20,000 PCP 10 15-20 COC 20 35-40 d-METH 50 50-70 MDMA 50 100-150 d-AMP 50 250-300 iScreen manufactured for iTechnology Drug Class Detection Capabilities: AMP/MAMP/THC/PCP/COC/OPI Double Membrane immunoassay Temperature Requirements: 2-30C Purchase Price: $12.00/per test (sold in boxes of 25 tests) Shelf Life: 12-14 months Test Time: No mention of time allowed w/ clean oral cavity prior to oral fluid collection, 3 minute saliva collection, result interpretation at 10 minutes Test Materials Provided: Test Device, collector, procedure card, and package insert (same as above device) Confirmation Services: No confirmatory lab referral Oral Fluid Collection Testimonials: Same exact collector/Lot# as Oral Fluid Drug Screen Device, Unpleasant burnt/bitter taste, rigid inflexible collector that leaves an offensive after-taste, several donors requested to rinse cavity and spit after collection process was complete Manufacturer/Product Services: No customer or technical support offered, no product training available No automated result analyzer available for this product Sold to distributors only Testing Observations: 2 different oxycodone cutoffs were reported, insert provides THC-COOH cut-off, every test device was covered w/ a film of dust and dirt, this test requires larger amounts of sample to work, confirmation container leaked on several devices, lines began at the top and bottom edge and migrated inwards which made partial line formation Line intensity:

    9. LOT# iDOA765011 Exp. 01/2006 Advertised Cut-offs (ng/ml) Tested Cut-offs (ng/ml) THC-COOH 4 750-1,000 NATIVE-THC 10,000 24,000-26,000 OPI 40 >20,000 OXY 6,000-25,000 >20,000 PCP 10 15-20 COC 20 35-40 d-METH 50 50-70 MDMA 50 100-150 d-AMP 50 250-300 iScreen manufactured for iTechnology Drug Class Detection Capabilities: AMP/MAMP/THC/PCP/COC/OPI Double Membrane immunoassay Temperature Requirements: 2-30C Purchase Price: $12.00/per test (sold in boxes of 25 tests) Shelf Life: 12-14 months Test Time: No mention of time allowed w/ clean oral cavity prior to oral fluid collection, 3 minute saliva collection, result interpretation at 10 minutes Test Materials Provided: Test Device, collector, procedure card, and package insert (same as above device) Confirmation Services: No confirmatory lab referral Oral Fluid Collection Testimonials: Same exact collector/Lot# as Oral Fluid Drug Screen Device, Unpleasant burnt/bitter taste, rigid inflexible collector that leaves an offensive after-taste, several donors requested to rinse cavity and spit after collection process was complete Manufacturer/Product Services: No customer or technical support offered, no product training available No automated result analyzer available for this product Sold to distributors only Testing Observations: 2 different oxycodone cutoffs were reported, insert provides THC-COOH cut-off, every test device was covered w/ a film of dust and dirt, this test requires larger amounts of sample to work, confirmation container leaked on several devices, lines began at the top and bottom edge and migrated inwards which made partial line formation Line intensity:LOT# iDOA765011 Exp. 01/2006 Advertised Cut-offs (ng/ml) Tested Cut-offs (ng/ml) THC-COOH 4 750-1,000 NATIVE-THC 10,000 24,000-26,000 OPI 40 >20,000 OXY 6,000-25,000 >20,000 PCP 10 15-20 COC 20 35-40 d-METH 50 50-70 MDMA 50 100-150 d-AMP 50 250-300 iScreen manufactured for iTechnology Drug Class Detection Capabilities: AMP/MAMP/THC/PCP/COC/OPI Double Membrane immunoassay Temperature Requirements: 2-30C Purchase Price: $12.00/per test (sold in boxes of 25 tests) Shelf Life: 12-14 months Test Time: No mention of time allowed w/ clean oral cavity prior to oral fluid collection, 3 minute saliva collection, result interpretation at 10 minutes Test Materials Provided: Test Device, collector, procedure card, and package insert (same as above device) Confirmation Services: No confirmatory lab referral Oral Fluid Collection Testimonials: Same exact collector/Lot# as Oral Fluid Drug Screen Device, Unpleasant burnt/bitter taste, rigid inflexible collector that leaves an offensive after-taste, several donors requested to rinse cavity and spit after collection process was complete Manufacturer/Product Services: No customer or technical support offered, no product training available No automated result analyzer available for this product Sold to distributors only Testing Observations: 2 different oxycodone cutoffs were reported, insert provides THC-COOH cut-off, every test device was covered w/ a film of dust and dirt, this test requires larger amounts of sample to work, confirmation container leaked on several devices, lines began at the top and bottom edge and migrated inwards which made partial line formation Line intensity:

    12. Random Testing Solution Avitar CASE STUDY #1 Illicit Drug Usage Reduced 9x from 7.0% to 0.8% ! Archer Daniels Midland $30B Corporation Like the majority of U.S. corporations, ADM traditionally implemented a pre-employment drug testing program that relied on laboratory urine testing services. Senior management realized, however, that pre-employment screening delivered a limited solution to workplace drug abuse. By implementing a corporate-wide Avitar oral-based random drug testing program, ADM, a $30B+ U.S. manufacturing company, reduced employee illicit drug usage from a 7% positive rate to less than 1%. Key elements of the ongoing drug free workplace program which covered all levels of the organization, include a centrally managed drug testing program, an effective communications program, and a comprehensive intranet-based management / reporting software system. Using available industry data, ADM is realizing an estimated $17M annual ROI. Like the majority of U.S. corporations, ADM traditionally implemented a pre-employment drug testing program that relied on laboratory urine testing services. Senior management realized, however, that pre-employment screening delivered a limited solution to workplace drug abuse. By implementing a corporate-wide Avitar oral-based random drug testing program, ADM, a $30B+ U.S. manufacturing company, reduced employee illicit drug usage from a 7% positive rate to less than 1%. Key elements of the ongoing drug free workplace program which covered all levels of the organization, include a centrally managed drug testing program, an effective communications program, and a comprehensive intranet-based management / reporting software system. Using available industry data, ADM is realizing an estimated $17M annual ROI.

    13. The experiences of Gould Construction, a Colorado based heavy equipment and highway contractor, clearly demonstrate the direct relationship between drugs-of-abuse and accidents within the workplace. Construction is the most dangerous job in America (U.S. DOL), and also has one of the highest drug abuse rates among its workforce, at 25% or more (SAMSHA). By implementing Avitars on-site testing solution, Gould Construction was able to reduce accidents from 19 to 0, and associated workers comp claims, and reduce the Companys Workers Comp premium by 13%. Annual savings to Gould total over $1.5M. The experiences of Gould Construction, a Colorado based heavy equipment and highway contractor, clearly demonstrate the direct relationship between drugs-of-abuse and accidents within the workplace. Construction is the most dangerous job in America (U.S. DOL), and also has one of the highest drug abuse rates among its workforce, at 25% or more (SAMSHA). By implementing Avitars on-site testing solution, Gould Construction was able to reduce accidents from 19 to 0, and associated workers comp claims, and reduce the Companys Workers Comp premium by 13%. Annual savings to Gould total over $1.5M.